Overview

A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets

Status:
Not yet recruiting
Trial end date:
2023-10-15
Target enrollment:
Participant gender:
Summary
To assess the relative bioavailability of SHR7280 dry suspension and tablets in healthy subjects. To assess the safety and tolerability of a single dose of SHR7280 dry suspension and tablets.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.